scispace - formally typeset
J

J. Mason

Researcher at Kingston University

Publications -  35
Citations -  343

J. Mason is an academic researcher from Kingston University. The author has contributed to research in topics: Liquid crystal & Optical fiber. The author has an hindex of 8, co-authored 35 publications receiving 341 citations. Previous affiliations of J. Mason include Institute of Technology, Carlow & Queen's University Belfast.

Papers
More filters
Proceedings ArticleDOI

Construction and calibration of a new design of fiber optic respiratory plethysmograph (FORP)

TL;DR: Improvements to signal processing and the increased sensitivity of the new design now make it practicable to detect torso motion arising from cardiac activity, and results show the simultaneous monitoring of respiratory and cardiac signals, using only the FORP transducers.
Journal ArticleDOI

Improved fibre optic respiratory monitoring using a figure-of-eight coil.

TL;DR: The macro-bending loss effect in optical fibres has been used to redevelop a sensor for the measurement of thoracic and abdominal circumferences in non-invasive respiratory monitoring, which uses a novel figure-of-eight loop configuration that results in increased linearity of response, less mechanical resistance and hysteresis, as well as other benefits.
Journal ArticleDOI

The capacitive drop tensiometer: a novel multianalysing technique for measuring the properties of liquids

TL;DR: In this paper, a new instrumental method for measuring the physical properties of a liquid has been developed, called a capacitive drop tensiometer (CDT), which is based on the drop volume principle in combination with the capacitive transducer.
Patent

Apparatus and method for measuring a property of a liquid

TL;DR: In this article, a fingerprint of a liquid sample is used to distinguish and analyse a variety of liquid samples, and the fingerprint can be used in distinguishing and analysing a wide range of liquids.
Journal ArticleDOI

Cell Therapy Companies Make Strong Progress from October 2012 to March 2013 Amid Mixed Stock Market Sentiment

TL;DR: During Q4 2012 and Q1 2013, the cell therapy industry made strong progress in translation and commercialization, suggesting emergence of this industry as a distinct healthcare sector.